Toggle Main Menu Toggle Search

Open Access padlockePrints

Evaluation of spinning disk reactor technology for the manufacture of pharmaceuticals

Lookup NU author(s): Professor Colin Ramshaw

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

A continuously operating spinning disk reactor (SDR) displayed distinct advantages over batch processing techniques when several commercially relevant processes for the manufacture of pharmaceuticals as test reactions were investigated. It proved to be a useful tool for revealing intrinsically fast kinetics as well as for optimizing processes with such kinetics. Very encouraging results were achieved for a phase-transfer-catalyzed (ptc) Darzen's reaction to prepare a drug intermediate and the recrystallization of an active pharmaceutical ingredient (API). In comparison to presently used batch processes, the ptc reaction resulted in a reaction with 99.9% reduced reaction time, 99% reduced inventory, and 93% reduced impurity level. The recrystallization yielded particles with a tight particle size distribution and a mean size of around 3 mu m. Reactor modeling was in good agreement with the experimental results and highlighted the advantages of the process-intensified equipment,with a production capacity of around 8 tonnes/year.


Publication metadata

Author(s): Oxley P, Brechtelsbauer C, Ricard F, Lewis N, Ramshaw C

Publication type: Article

Publication status: Published

Journal: Industrial & Engineering Chemistry Research

Year: 2000

Volume: 39

Issue: 7

Pages: 2175-2182

ISSN (print): 0888-5885

ISSN (electronic): 1520-5045

Publisher: American Chemical Society

URL: http://dx.doi.org/10.1021/ie990869u

DOI: 10.1021/ie990869u


Altmetrics

Altmetrics provided by Altmetric


Share